The homopolymer, poly(3-hydroxyoctanoate), P(3HO), as a matrix material for soft tissue engineering by Rai, Ranjana et al.
1 
 
The homopolymer, poly(3­hydroxyoctanoate), 
P(3HO), as a matrix material for soft tissue 
engineering 
 
Ranjana Raia,  Aldo R. Boccaccini b,c, Jonathan C. Knowlesd,e,  
Nicola Mordond, Vehid Salihd, Ian C. Lockef, M. Moshrefi-Torbatig,  
Tajalli Keshavarza and Ipsita Roya* 
aDepartment of Molecular and Applied Bio Sciences, School of Life Sciences, University of Westminster, 
London W1W 6UW, UK 
bDepartment of Materials, Imperial College London, London SW7 2AZ, UK 
cDepartment of Materials Science and Engineering, University of Erlangen – Nuremberg Cauestr. 6., 91058 
Erlangen, Germany. 
dDivision of Biomterials and Tissue Engineering, UCL Eastman Dental Institute, London WCIX 8LD, UK 
eWCU Research Centre of Nanobiomedical Science, Dankook University, San#29, Anseo­dong,  
Dongnam­gu, Cheonan­si, Chungnam, 330­714, South Korea 
fDepartment of Biomedical Sciences, School of Life Sciences, University of Westminster,  
London W1W 6UW, UK 
gSchool of Engineering Sciences, University of Southampton, Southampton SO171BJ, UK 
 
 
 
 
 
  
2 
 
Abstract 
 
The homopolymer poly(3-hydroxyoctanoate), P(3HO) produced from Pseudomonas  
mendocina using octanoate as carbon feed was studied as a potential biomaterial for soft 
tissue engineering i.e. as cardiac patch and as matrices for skin tissue engineering. The 
polymer was fabricated into neat solvent cast films of 5 and 10 wt %. Microstructural studies 
revealed the films as having smooth surface topography with a root mean square (RMS) 
value of 0.238 µm. The films also possessed moderate hydrophilicity when compared to other 
monomers of the PHA family. Stress-strain curves of the films obtained was typical of that of 
elastomeric polymers. This elastomeric and flexible nature of the films makes them 
promising candidates for the proposed applications. Biocompatibility studies using the 
HaCaT keratinocyte cell line showed that the films were able to support the attachment, 
differentiation and maturation of the HaCaT cells. In vitro degradation studies over a period 
of 4 months showed that the water absorption and weight loss increased progressively with 
time for the films. The films underwent hydrolytic degradation initiated on the surface and 
also showed an ageing effect. 
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INTRODUCTION 
In the early 1990s a paradigm shift occurred in medicine from using synthetic and tissue 
grafts to a tissue engineering approach in order to address limitations of tissue grafting and 
alloplastic tissue repair [1, 2]. The approach is based on the fundamental notion  that the body 
is able to heal itself [3] and involves the complex interactions between cells genes and/or 
numerous proteins within a porous degradable matrix material known as scaffold [2]. The 
scaffold or matrix material, far from being a passive component, plays an important role in 
tissue regeneration by preserving tissue volume, delivering biofactors and providing 
temporary mechanical support [1, 2] An ideal scaffold must be biocompatible, balance 
mechanical function with tissue delivery and have degradability tailored to match tissue 
regenerative rate.  
Numerous studies have been carried out on synthetic, natural and a combination of natural 
and synthetic materials for their use as scaffold/matrix for a wide ranging tissue engineering 
application [4, 5]. One such family of natural materials (biopolymers) attracting great interest 
as a scaffold material are the polyhydroxyalkanoates, PHAs. PHAs are polyesters of 3-
hydroxyacids biosynthesized by numerous Gram positive and Gram negative bacteria under 
nutrient(s) limiting conditions like nitrogen, potassium, sulphur, magnesium and phosphate, 
in the present of excess carbon source [6, 7]. These are accumulated as intracellular carbon and 
energy storage granules by fermentation of renewable resources. The PHAs may be short 
chain length (scl) containing C3 to C5 carbon atoms or medium chain length (mcl) containing 
C6 to C14 carbon atoms.  Once extracted, PHAs exhibit properties ranging from hard and 
brittle to soft and elastomeric in nature. Scl-PHAs like poly(3-hydroxybutyrate), P(3HB), are 
hard and brittle in contrast to mcl-PHAs and their copolymers like poly(3-hydroxyhexanoate-
co-3-hydroxyoctanoate), P(3HHx-co-3HO) that are soft and elastomeric. In addition to these 
wide ranging physical properties exhibited by the PHAs, this family of biopolyester are also 
biodegradable, bioresorbable and biocompatible. Owing to these amenable properties 
numerous studies have been carried out using PHAs as scaffold for hard and soft tissue 
engineering. The hard and brittle scl-PHA like P(3HB) has been studied for hard tissue 
engineering such as bone and the soft and elastomeric PHAs like P(3HHx-co-3HO) have 
been studied for soft tissue engineering such as heart valves, other vascular applications, skin 
tissue engineering and wound healing applications [5, 8]. 
4 
 
We have successfully produced a homopolymer, poly(3-hydroxyoctanoate), P(3HO), from P. 
mendocina using octanoate as the feed. Detailed structural, mechanical, thermal and 
molecular weight analyses of this polymer have been carried out [9].  In this work we 
describe, for the first time, the fabrication of the P(3HO) homopolymer into neat two 
dimensional films. A detailed microstructural, thermal, mechanical, in vitro degradation and 
biocompatibility assessment of the films has been carried out in order to assess the potential 
of P(3HO) as a matrix material for soft tissue engineering such as cardiac patch application 
and as support material for skin tissue engineering. 
Myocardial infarction is one of the major causes of death in patients suffering from 
cardiovascular diseases (CVD). Treatment to date has relied on heart transplantation and the 
use of ventricular assisted devices (VAD). However, lack of organ donors and high cost of 
VADs have presented serious limitations. An alternative approach is to deliver cardiac cells 
to the heart by using a tissue engineering strategy; here a biodegradable patch would be 
populated, in vitro, with cardiac cells and then implanted onto the infarct region [10]. In this 
study the P(3HO) neat film is proposed to be used as a cardiac patch material. The cardiac 
patch will serve two functions, delivery of healthy cardiac cells into the infarct region and to 
provide left ventricular (LV) restrain, since myocardial infarction can impair overall pump 
function of the left ventricle leading to congestive heart failure.  
Also, in the context of skin tissue engineering, another possible application of P(3HO) 2D 
films is to use it as matrices for engineering skin tissues which could be used for wound 
healing. The human skin is the largest organ of the body. The skin protects the body from the 
external environment by maintaining temperature and haemostasis in addition to performing 
sensory detection. Skin tissue engineering is very important as it is needed to provide skin 
grafts to permanently replace damaged or missing skin or to provide a temporary wound 
covering to burn victims, also for non healing wounds such as diabetic ulcers, venous ulcers 
and cosmetic surgery. Damaged skin or a non healing wound could compromise the health of 
an individual [11]. Much research has been carried out on the development and clinical use of 
tissue engineered skin. Skin cells have been seeded and populated into suitable films. The 
skin cell film construct is then grafted to the wound; cells then proliferate from the film to the 
wound bed forming cell clusters and ultimately the normal epidermis. The film in addition to 
supplying healthy cells also provides protection to the wound until it is degraded or absorbed 
[12, 13].  
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EXPERIMENTAL PART 
Fabrication of films:  
The homopolymer P(3HO) was produced from P. mendocina using octanoate as described 
elsewhere  [9].  Neat P(3HO) films were fabricated using the solvent casting method. The 
films were fabricated by using 5 and 10 % of the polymer in 10 mL of CHCl3. The polymer 
was well dissolved after which the polymer solution was filtered and the films made by 
casting the polymer solution into glass petri dishes. The solution was then left to air dry at 
room temperature for 1 week followed by freeze drying for 10 days.  
Microstructural studies: 
Scanning electron microscopy (SEM) 
Microstructural studies for the surface topography were also carried out using a JEOL 
5610LV scanning electron microscope. The samples were placed on 8 mm diameter 
aluminium stubs and then sputter coated with gold using an EMITECH-K550 sputtering 
device. The operating pressure of 7 x 10-2 bar and deposition current of 20 mA for 2 minutes 
were used. The SEM images were taken with an acceleration voltage of 15 kV (maximum) to 
avoid incineration of the polymer due to the beam heat. 
White light interferometry study (Zygo®)  
White light interferometry was used to obtain 3D images of the surface topography of 
samples by means of the analyzer Zygo® (New View 200 OMP 0407C). This measurement 
allowed the quantification of the roughness and investigation of the topography of the 
surfaces.  
Contact angle study 
Static contact angle measurements were carried out to evaluate the wettability i.e. 
hydrophilicity of the fabricated films. A gas tight microsyringe was used to place an equal 
volume of water (<10 l) on every sample by means of forming a drop. Photos (frame 
interval of 1 second, number of frames = 100) were taken to record the shape of the drops. 
The water contact angles on the specimens were measured by analysing the recorded drop 
images using the Windows based KSV CAM software. Six repeats for each sample were 
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carried out. The experiment was done on a KSV CAM 200 optical contact angle meter (KSV 
Instruments Ltd). 
Mechanical properties 
Tensile testing was carried out using a Perkin–Elmer dynamic mechanical analyzer at room 
temperature. The test was carried out on polymer strips of 10 mm length and 4 mm width, cut 
from the solvent cast polymer films. The initial load was set to 1 mN and then increased to 
6000 mN at the rate of 200 mN min-1. The test was carried out on 6 repeats of the samples. 
Young’s modulus, stress and strain were recorded during the test. The Young’s modulus was 
calculated from the initial strain range as described in the literature [14] i.e. when the polymer 
had strained up to 15%. 
Thermal properties 
The thermal properties of the polymer,  i.e. glass transition temperature (Tg) and melting 
temperature (Tm) were measured by carrying out differential scanning calorimetry (DSC) 
using a Perkin Elmer Pyris Diamond DSC (Perkin Elmer Instrument). The amount of 
polymer used for the study ranged from 8 to 10 mg and the sample was encapsulated in 
standard aluminium pans. All tests were carried out under inert nitrogen. The samples were 
heated/cooled/heated at a heating rate of 20oC min-1 between -57oC and 100oC. The test was 
carried out on 9 repeats of the samples.  
In vitro degradation studies 
In vitro degradation studies of the fabricated 2D films were carried out. The degradation 
behaviour was studied for a period of 1, 2 and 4 months in phosphate buffer saline (PBS), 
Dulbecco’s Modified Eagles Medium (DMEM) and Dulbecco’s Modified Eagles Medium 
Knock Out (DMEMKT).  
PBS was chosen since it is one of the buffer systems that regulate the acid or base balance in 
the body.  DMEM medium was chosen since the biocompatibility studies for the fabricated 
films were carried out using the HaCaT cell line and DMEM was the medium chosen to 
culture these cells. Similarly, DMEMKT medium was also chosen since for pericardial patch 
application, the films would be seeded with embryonic stem cells and DMEMKT is one of the 
most optimum culture media types that support the growth of these cells. 
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Water uptake, weight loss and pH measurements 
The degradation kinetics was determined by measuring the % water uptake or absorption (% 
WA) and % weight loss (% WL). For these, all the samples were first weighed to obtain the 
dry weight Mo (Mo, the initial weight of the sample), immersed in the respective media and 
kept under static conditions, at 37oC, until no further weight loss was evident. The medium 
was changed once a week. At each prescheduled incubation time point the films were 
collected and analysed for water absorption (% WA) and weight loss (% WL) behaviour. For 
measuring the % WA of the samples, the immersed samples were removed at given time 
points, the surface was gently wiped with a tissue paper and the weight was measured Mw, 
wet (Mw, the weight of the samples after immersion in the medium). Similarly, for measuring 
the % WL, the samples were withdrawn from the medium, washed several times with 
deionised water and dried at 37oC overnight and subsequently weighed Mt, dry (Mt, the dry 
weight of the samples after immersion in the media followed by drying). Water absorption 
and weight loss were calculated using the following equations: 
 
 
The medium in which the films were incubated were changed every week. The pH changes of 
the media were then measured at the end of each incubation time point at ambient conditions. 
Mechanical properties 
The in vitro degraded films were studied for their mechanical properties and surface 
degradation using SEM as described above. 
Protein adsorption studies 
Protein adsorption assay was performed using foetal bovine serum, (FBS). Square films, (1 
cm2 in area), were incubated in 400 l of undiluted FBS, at 37oC, for 24 hrs. After 
incubation, the samples were rinsed with PBS, thrice. The samples were then incubated in 1 
mL of 2% sodium dodecyl sulfate (SDS) in PBS for 24 hrs at room temperature and under 
vigorous shaking to further collect the adsorbed proteins. The amount of total protein 
adsorbed on the surface of the samples was quantified using a commercial protein 
quantification kit (Pierce, Rockford, IL). The optical density of the samples was measured 
spectrophotometrically at 562 nm against a calibration curve using bovine serum albumin as 
% WA = [(Mw wet-Mt dry)/Mt dry]100 
 % WL = [(Mo dry-Mt dry)/Mo dry] 100 
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per the manufacturer’s protocol. The samples incubated in PBS were used as a negative 
control. The assay was carried out in triplicates. 
In vitro cytocompatibility study 
Cell culture study 
The in vitro cell culture studies were carried out on the P(3HO) neat films using the Human 
keratinocyte cell line, the HaCaT cell line, which was cultured in DMEM growth medium, 
supplemented with 10% foetal calf serum, 1% glutamine and 1% penicillin and streptomycin 
solution. The penicillin and streptomycin used was one solution. The cells were incubated at 
37oC in a 5% CO2 humidified atmosphere and culture medium changed every 2 days. 
Cell seeding on the test samples 
Polymer 2D films, 1 cm2 in area (square strips),were UV sterilised for 30 minutes on each 
side and passivated in culture medium for 12 h.  A cell density of 20,000 cells was used to 
seed the scaffolds, kept in 24 well plates. The cells were analysed after 1, 4 and 7 days for 
cell adhesion, proliferation and morphology. Cell culture studies were carried out on triplicate 
samples per experiment.  
Cell adhesion, proliferation and morphology  
Cell adhesion and proliferation studies were carried out using the Neutral Red (NR) assay as 
described elsewhere [15]. The total NR uptake was used as a measure of the cell’s proliferation 
and viability (% NR uptake is directly proportional to the number of live and uninjured cells) 
and was compared to a control population, grown on tissue culture plates. The control was 
normalised to 100%.  
SEM preparation for viewing of cells 
The P(3HO) films were examined under SEM in order to observe the HaCaT cell spreading 
and attachment on the surface of the samples. The specimens were fixed in  
3% glutaraldehyde in 0.1 M sodium cacodylate buffer, for 12 h, at 4oC. Samples were 
dehydrated using graded series of alcohols. The samples were then left to air dry for 30 min. 
The dried samples were then attached to aluminium stubs, gold coated and examined for 
SEM as described earlier. 
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RESULTS AND DISCUSSION 
Microstructural studies 
The fabricated neat P(3HO) films were subjected to a series of analyses to assess their surface 
and microstructural properties. Surface topography, roughness and wettability have been 
reported to play a pivotal role in the applicability of a potential biomaterial.  The surface 
study of the fabricated films (Figure 1A) using SEM (Figure 1B) revealed that the P(3HO) 
films had a smooth surface topography. Surface analysis of the films was also carried out by 
white light interferometry using a Zygo® instrument to visualise the topography of the films 
as shown in the surface scan in Figure 1C. White light interferometry analysis revealed a 
typical RMS value of 0.238 µm. The film had a smooth surface as opposed to the hard and 
brittle P(3HB) having a RMS value of 2.01 µm. 
Water contact angle studies of the fabricated films were also carried out to assess their 
wettability, i.e. hydrophilicity. Surfaces with θH2O less than 70o is considered to be 
hydrophilic and θH2O greater than 70o as hydrophobic [13]. Static contact angle measurements 
of the fabricated films are given in Table 1. For comparison, the contact angle values 
measured for other PHAs in literature are also included in the table. Therefore, in this study 
the fabricated neat P(3HO) with θH2O = 77.3o ± 1 (5 wt%) and θH2O = 78o ± 1 (10 wt%) were 
found to be more hydrophilic than most of the other PHAs, except for P(3HO) copolymer 
(containing 84.5 mol% C8,  6 mol% C6 and 4.3 mol% C10) which had a θH2O of 73.8o [16]. 
Mechanical properties 
In this study, no point of discontinuity in the slope of the stress-strain curve (commonly 
known as “knee”) [20] appeared for the 5 and 10 wt% films (Figure 2). The Young’s modulus 
values calculated from the slope of the curves were 1.40 ± 0.6 MPa for the 5 wt% film, 
Figure 2(A), and 3.09 ± 0.7 MPa for the 10 wt% film, Figure 2(B).  
The static tensile studies therefore showed that the fabricated films, like other mcl-PHAs 
reported in literature, exhibited an elastomeric nature. Marchessault et al. [21] found the 
Young’s modulus ‘E’ value for P(3HO) to be 17 MPa and the % elongation values ranging 
between 250-350% [21]. For mcl-PHA containing 86% of 3HO and minor quantities of 3-
hydroxydecanoate and 3-hydroxyhexanoate the ‘E’ value of the polymer film (1.6 mm 
thickness) was 7.6 ± 0.5 MPa and % elongation to break of 380% [22]. Similarly Asrar et al. 
[23] observed Young’s modulus values ranging from 155 to 600 MPa and elongation to break  
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ranging between 6.5 to 43% for P(3HO) thermally processed films (micrometer thick, values 
not given) containing 2.5 to 9.5 mol % of 3-hydroxyhexanoate (3HHx). In studies carried out 
by Ouyang et al. [24] mcl-PHA solvent casted films (100 m thick) containing different mol% 
of 3-hydroxydodecanoate, 3(HDD), i.e. 15, 28 and 39, had Young’s modulus values of 3.6, 
6.0 and 11.5 MPa respectively [24]. Thus, the Young’s modulus values of the fabricated films 
in this present study were relatively low when compared to other values reported in literature. 
This low stiffness, (E value) of the films could be due to the homopolymeric nature of the 
P(3HO) films, which because of the long carbon backbone of the same type (all C8 
monomers) were able to deform easily to dissipate the applied stress. Thus, this study has 
shown that the fabricated P(3HO) films were less stiff than most other PHAs described in 
literature.   
Thermal properties 
Thermal studies of the fabricated films were also carried out since thermal stability has an 
important implication on the material’s processability and end goal application. The thermal 
properties of the films are depicted in Figure 3(A-B) and summarised in Table 2. During the 
first heat scan the polymer chains in the crystalline phase of the polymer has melted and 
become disordered. This absorption of energy for the melting of the polymer chains in the 
crystalline phase was reflected as the Tm peak. Once melted, the polymer chains were unable 
to rearrange themselves into ordered structures during the cooling run following the first 
heating run. This inability of the melted polymer chains to rearrange themselves into ordered 
crystalline lattices, led to the absence of a Tm peak, representing the transition of the 
crystalline phase into the amorphous state during the second heat scan.  
In vitro degradation study 
The degradation behaviour of a matrix material is of paramount importance and greatly 
affects its potential as a biomaterial. In vitro degradation of the films was carried out in order 
to understand how these films degrade and how their physical and chemical properties 
change with degradation.  
Water absorption (%WA) and weight loss (%WL) behaviour of the films were studied over 
the incubation time period of 4 months. The results, Figure 4(A-B), showed that the films 
absorbed water and lost weight during the incubation period, thus indicating that the films 
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were undergoing degradation. Both the water absorption and the weight loss increased 
progressively with time in all the three media i.e. PBS, DMEM and DMEMKT.  
In a study carried out on the degradation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate), 
P(3HB-co-3HV), Holland et al. [25] observed water absorption in polymers during a 120 day 
experiment and found that increased water absorption was associated with progressive 
degradation of the samples. As the films in this study were only incubated in enzyme free 
media, the degradation of the films must have occurred due to abiotic non enzymatic 
hydrolysis. The water molecules react with the polymer, cleaving the ester bond, thus 
exposing the carboxylic acid group and the hydroxyl group. The degradation of the films 
commenced at the surface, as observed in the SEM images (Figure 5(A1-A2)), which shows 
degraded polymer flakes on the surface of the films. This is because unlike polymers like 
PLGA which is an amorphous polymer with water absorption resulting in bulk degradation, 
in P(3HO), a semi crystalline polymer, degradation is mulphiphasic like that observed with 
the broader PHA family.  
In the first stage, spanning a few weeks, the amorphous phase of the polymer begins to 
degrade. This is because the crystalline regions of the polymer are impermeable to water, 
hydrolysis is therefore restricted to the amorphous regions of the polymer and to the fringes 
of the crystalline region [26]. Next, the crystalline part of the polymer begins to degrade 
resulting in the formation of monomers, dimers and tetramers; simultaneously the molecular 
mass also decreases. Progressively with time, the degradation process develops and the 
polymer loses its mass [27]. Such hydrolytic degradation of PHAs have been previously 
described in literature and is known to be a slow process when compared to the enzymatic 
hydrolysis of PHAs [28]. This is because of the relatively high crystallinity of PHAs which 
leads to increased impermeability of water into the crystalline regions [26] and also due to the 
hydrophobic nature of long alkyl pendant chains [29]. This slow hydrolytic degradation could 
be a reason why the fabricated films had lost only 15% of their weight by the end of the 
degradation studies. However, the water absorption and weight loss observed in this study for 
the neat films were higher than those observed for other PHAs, also studied for hydrolytic 
degradation. For instance, no significant weight loss was observed when P(3HB), P(3HB-co-
3HV) samples were incubated for 180 days, at 37°C, in aqueous media [30, 31].  Marios et al. 
[28] studied the in vitro degradation of the P(3HO) film containing 3 mol% 3HHx in water and 
phosphate buffer saline. The films showed negligible mass loss of less than 1% after 24 
months of incubation [28]. Numerous factors affect the biodegradability of PHAs such as 
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stereoregularity, molecular mass, monomeric composition and crystallinity of the polymer. 
Studies carried out by Mochizuki [32] and Tokiwa and Calabia [33] showed that biodegradation 
of PHAs is influenced by the chemical structure (i.e. the presence of functional groups in the 
polymer chain, hydrophilicity / hydrophobicity balance) and presence of ordered structure 
such as crystallinity, orientation and morphological properties [32, 33]. Usually the degradation 
of the polymer decreases with the increase of highly ordered structure i.e. increased 
crystallinity. Since the P(3HO) used in this study has lower crystallinity than P(3HB) and 
P(3HB-co-3HV) [30, 31] the fabricated P(3HO) films could be expected to be more degradable 
than P(3HB) and P(3HB-co-3HV), described in literature. 
In this present study, the pH of all the three media, PBS, DMEM and DMEMKT, in which the 
neat films were incubated, increased progressively with time (Figure 6). The degradation of 
the P(3HO) films would result in the production of  3-hydroxyoctanoate or 3-
hydroxyoctanoic acid depending on the pH of the media. If hydroxyoctanoic acid is denoted 
as HA, then its dissociation upon release after degradation can be represented as:  
 
The pKa for 3-hydroxyoctanoic acid is 4.89. Since the pH of all the three media was 7.4, 
which is greater than the pKa of the acid (4.89), most of the acid molecules would exist in the 
form of 3-hydroxyoctanoate, a base, leading to an increase in the pH of the media in which 
the films were incubated. 
When mechanical testing of the degraded films was carried out it was found that the 
Young’s modulus of the polymer had increased after two months of incubation and again 
showed a reduction of the modulus after 4 months of incubation, as shown in Figure 7. 
Although the Young’s modulus had decreased at 4 months, the value was still higher than 
those observed for the undegraded films. This increase in the Young’s modulus of the films 
after degradation could be due to the ageing of the polymer [34]. The ageing in PHAs occurs 
due to the secondary crystallisation of the PHAs which involves the development of the 
interlamellar secondary crystals in the amorphous region of the semi crystalline polymer. The 
small crystallites produced restrict the motion of the polymer chains in the amorphous 
regions, thereby reducing the mobility of the polymer chain segments; thus raising the 
modulus and increasing the brittle nature of the material [35]. Many PHAs have been reported 
to show ageing behaviour [23, 35-37]. For example, when Asrar et al. [23] aged the copolymer 
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P(3HB-co-8.1 mol% 3HHx) for 11 days at room temperature, the Young’s modulus increased 
from 18.8 MPa to 22.8 MPa.  Alata et al. [36] studied the ageing effect on the mechanical 
properties of P(3HB-co-3HHx) containing different mol % of 3HHx, ranging from 5 to 18 
mol%. After 60 days of ageing they found that the % elongation to break had decreased and 
the tensile strength had increased for all the copolymers. Similar observations were made for 
P(3HB) and copolymer of P(3HB-co-3HV) [35].  
This ageing effect exhibited by the films in this present study is not desirable. This could be 
overcome by incorporating suitable hydrophilic polymers or plasticizers in the films. Such 
addition could also be employed for tailoring the degradation rate of the films, as addition of 
amorphous or hydrophilic additives lead to higher water absorption and accelerate hydrolysis. 
For example, the water content was found to be higher in P(3HB)/P(DL-lactic acid) than in 
P(3HB)/polycaprolactone [38].   
In tissue engineering, it is important that the effect of the degradation products on cellular 
behaviour is considered for a comprehensive biocompatibility evaluation of the implant 
polymers.  Studies were carried out by Sun and his group in 2007 [39], on the cellular 
responses of mouse fibroblast cell line L929 to the PHA degradation products, i.e. oligo-
hydroxyalkanoates (OHAs). They found that the cytotoxicity of OHAs decreased with 
increasing OHA side chain length, thus indicating that medium chain length OHAs 
containing PHA, such as poly(3-hydroxybutyrate-co-3-hydroxyhexanoate), P(3HB-co-3HHx) 
and mcl-PHAs are more biocompatible than scl-PHAs. Therefore, degradation products of the 
fabricated neat P(3HO) films in this study can also be expected to have decreased the 
cytotoxic effect on the  seeded cells as compared to the scl-PHAs, an important requirement 
for a biomaterial.  
Protein adsorption and in vitro cell biocompatibility 
Many studies have been carried out to understand the cell and material interfacial 
relationships, particularly related to protein adsorption. This is because most mammalian 
cells are anchorage dependent and need a biocompatible protein rich surface for attachment, 
differentiation and migration to form new tissue [40-42]. It has been shown that cell adhesion 
takes place in two different stages. The first stage consists of the adsorption of water and a 
layer of proteins that selectively adhere onto the biomaterial surface, mediated by the surface 
properties of the substrate [43]. The second stage involves cell adhesion onto the layer of 
proteins, which is a more complex process, mediated by the extracellular matrix (ECM) 
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proteins, cell membrane proteins, and cytoskeletal proteins [42, 44]. Protein adsorption can thus 
modulate cell adhesion and survival. Therefore, protein adsorption is important in evaluating 
a film for tissue engineering. The adsorption of proteins onto the fabricated films, in the 
present study, was carried out using the whole protein serum. The total proteins adsorbed 
onto the surface of the films were 75 and 83.17 µg/cm2 for the 5 and 10 wt% films 
respectively. 
The in vitro cell biocompatibility studies of the films were carried out by seeding HaCaT 
cells onto the films and studying its proliferation over a duration of 1, 4 and 7 days. The 
results (Figure 8) show that the cell proliferation increased progressively on all the films and 
at day 7, the proliferation was 58.42% (5 wt% film) and 73.09% (10 wt% film) of the control. 
Keratinocytes are known to form four distinct layers and divide and differentiate as they 
move from the deeper layer to the outermost layers. This arrangement of cell layers from the 
bottom to the outermost is as follows: (1) stratum basale (basal layer) (2) stratum spinulosum 
(spiny or prickle cell layer), (3) stratum granulosum (granular layer) and (4) stratum corneum 
(horn sheet layer) [45]. SEM scans (Figure 9) of the cells also confirmed that the polymer 
matrix was able to support cell growth, differentiate and mature successfully into horn sheets 
at day 7.   
Properties of films and their suitability for the proposed applications 
Poly­3­hydroxyoctanoate, P(3HO) neat  film as a potential biomaterial  for 
cardiac patch use 
The flexible and elastomeric nature of the films make them potentially suitable as 
biomaterials for heart patch application based on their stiffness, i.e. Young’s modulus values. 
Table 3 compares the properties of the various biomaterials which have been used for cardiac 
tissue engineering with the fabricated 5 wt% P(3HO) film in this study. Other biomaterials 
being studied for the application seem to be either too stiff, such as poly glycolic acid, 
(PGA), poly(L-lactic acid),  (PLLA) or poly(DL-lactide), (PDLLA), whose Young’s modulus 
value range in GPa or are very soft like collagen gel whose Young’s modulus value is in the 
range 0.002-0.022 MPa. The stiffness of the fabricated P(3HO) films, in particular the 5 wt% 
film, is comparable to the higher end stiffness value of polyglycerol sebacate, PGS, ranging  
from 0.04 to 1.2 MPa, which is a synthetic polymer being studied as material for patch 
applications [46, 47].  An interesting point is that the property of P(3HO) can be tailored by 
various methods such as grafting acrylamide and carboxyl ions using plasma treatment [48] 
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and by blending it with other biocompatible elastomeric polymers such as collagen, so that its 
mechanical properties can match either the stiffness of the heart muscle at the beginning of 
diastole (stiffness is 10–20 kPa) or the stiffness at the end of diastole (200–500 kPa) [46].  
 
P(3HO) film as a matrix for skin tissue engineering 
Numerous studies have been carried out on a number of natural, synthetic and a combination 
of natural and synthetic materials for skin tissue engineering applications [58, 59].  Some of the 
PHA monomers have also been studied as matrices for skin tissues such as P(3HB), P(3HB-
co-3HV), P(3HB-co-4HB), P(3HB-co-3HHx) [13, 18]. However, up to now, P(3HO) has never 
been studied in the context of skin tissue engineering. To the author’s knowledge this is the 
first such study of a homopolymer of P(3HO) and its biocompatibility with HaCaT cells.    
In spite of the fact that tissue engineered skin is now a reality, challenges are still faced in 
allowing cultured mass skin cells to attach securely, often to very challenging wound beds. 
The stability of keratinocyte attachment to the underlying dermis is also an important issue 
when delivering keratinocytes to deep burns and wound beds, especially if such burns and 
wound beds are located in difficult contours of the body. Therefore, in such a case having a 
flexible and elastomeric support would be ideal, hence P(3HO) films fabricated in this study 
being flexible and elastomeric would easily fit into such difficult contours of the body. 
However, the mechanical properties, the Young’s modulus value and the tensile strength of 
the fabricated P(3HO) films were found to be lower when compared to human skin [60]. One 
possible approach of improving the mechanical properties of the films in order to match the 
properties of human skin would be to blend P(3HO) with other biocompatible and 
mechanically suitable material for skin such as chitosan, (CH), hyaluronic acid and or poly(4-
hydroxybutyrate), P(4HB) [13]. Blends of P(4HB)/Ha and P(4HB)/CH  have been found to 
have mechanical properties suitable for human skin. Table 4 compares the properties of the 
various biomaterials which have been used for skin tissue engineering.  
 
CONCLUSION 
The homopolymer P(3HO) produced from P. mendocina was fabricated into films and 
studied for its suitability as a potential material for cardiac patch application and skin 
regeneration. The films were studied for their surface, microstructural, physical, in vitro 
16 
 
degradation behaviour and biocompatibility properties. Mechanically the films were found to 
possess flexible and elastomeric nature, a requirement in the proposed areas of applications. 
Biocompatibility studies showed that the films were able to support cell attachment, 
differentiation and maturation of the seeded HaCaT cells. This initial data suggests that 
P(3HO) films may be a potential for soft tissue engineering.    
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